Cardiovascular Business December 12, 2024
Dave Fornell

The United States spends more on healthcare than any other nation, but continues to see poor outcomes, according to U.S. Food and Drug Administration (FDA) Commissioner Robert Califf, MD. Speaking at the Transcatheter Cardiovascular Therapeutics (TCT) 2024 meeting on the topic, Califf emphasized the urgent need for systemic reform in the nation’s approach to healthcare. He listed rising infant mortality rates and declining life expectancy as two significant indicators of a broader crisis.

Califf, a cardiologist who previously served as a professor of cardiology at Duke University School of Medicine and was the founding director of the Duke Clinical Research Institute, pointed out that the U.S. lags behind other high-income nations in key health metrics despite its advanced technology and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Healthcare System
FDA warns GLP-1 compounder over safety rules
GLP-1 drug approvals: A breakdown
Rethinking FDA’s Accelerated Approval Pathway: New Draft Guidances and Implications for Drug Companies
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use
Certainty vs. speed: How do patients feel about the tradeoff for new cancer drugs?

Share This Article